Literature DB >> 22225506

The withdrawal of Activated Protein C from the use in patients with severe sepsis and DIC [Amendment to the BCSH guideline on disseminated intravascular coagulation].

Jecko Thachil, Cheng Hok Toh, Marcel Levi, Henry G Watson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22225506     DOI： 10.1111/j.1365-2141.2011.09019.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  12 in total

1.  Inhibition of factor XI activation attenuates inflammation and coagulopathy while improving the survival of mouse polymicrobial sepsis.

Authors:  Erik I Tucker; Norah G Verbout; Philberta Y Leung; Sawan Hurst; Owen J T McCarty; David Gailani; András Gruber
Journal:  Blood       Date:  2012-03-22       Impact factor: 22.113

2.  Anti-Inflammatory Effects of Lysozyme Against HMGB1 in Human Endothelial Cells and in Mice.

Authors:  Wonhwa Lee; Sae-Kwang Ku; Dong Hee Na; Jong-Sup Bae
Journal:  Inflammation       Date:  2015-10       Impact factor: 4.092

3.  Wnt5A/Ryk signaling critically affects barrier function in human vascular endothelial cells.

Authors:  Tom Skaria; Esther Bachli; Gabriele Schoedon
Journal:  Cell Adh Migr       Date:  2016-05-09       Impact factor: 3.405

4.  Modulating the rate of fibrin formation and clot structure attenuates microvascular thrombosis in systemic inflammation.

Authors:  Christian Valladolid; Marina Martinez-Vargas; Nitin Sekhar; Fong Lam; Cameron Brown; Timothy Palzkill; Alexander Tischer; Mathew Auton; K Vinod Vijayan; Rolando E Rumbaut; Trung C Nguyen; Miguel A Cruz
Journal:  Blood Adv       Date:  2020-04-14

5.  Learning from mistakes in clinical practice guidelines: the case of perioperative β-blockade.

Authors:  Mark D Neuman; Charles L Bosk; Lee A Fleisher
Journal:  BMJ Qual Saf       Date:  2014-08-18       Impact factor: 7.035

Review 6.  Disseminated intravascular coagulation: a review for the internist.

Authors:  Marcel Levi; Tom van der Poll
Journal:  Intern Emerg Med       Date:  2012-09-27       Impact factor: 3.397

7.  Factor XII Activation Promotes Platelet Consumption in the Presence of Bacterial-Type Long-Chain Polyphosphate In Vitro and In Vivo.

Authors:  Jevgenia Zilberman-Rudenko; Stéphanie E Reitsma; Cristina Puy; Rachel A Rigg; Stephanie A Smith; Erik I Tucker; Robert Silasi; Alona Merkulova; Keith R McCrae; Coen Maas; Rolf T Urbanus; David Gailani; James H Morrissey; András Gruber; Florea Lupu; Alvin H Schmaier; Owen J T McCarty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-08       Impact factor: 8.311

8.  Thrombomodulin/activated protein C system in septic disseminated intravascular coagulation.

Authors:  Takayuki Ikezoe
Journal:  J Intensive Care       Date:  2015-01-07

9.  Revised algorithm for heparin anticoagulation during continuous renal replacement therapy.

Authors:  Helen Dickie; Linda Tovey; William Berry; Marlies Ostermann
Journal:  Crit Care       Date:  2015-10-27       Impact factor: 9.097

10.  Anti-septic effects of dabrafenib on HMGB1-mediated inflammatory responses.

Authors:  Byeongjin Jung; Hyejin Kang; Wonhwa Lee; Hyun Jin Noh; You-Sun Kim; Min-Su Han; Moon-Chang Baek; Jaehong Kim; Jong-Sup Bae
Journal:  BMB Rep       Date:  2016-04       Impact factor: 4.778
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.